Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway
Table 2
Antiepileptic drug use among patients () in home care services (HCS) and nursing homes. The association (odds ratio, OR) and 95% confidence interval (CI) for use of the drugs, adjusted for patients’ age, gender, and total number of drugs used in different settings (home care service used as reference).
Drug
Home care services ()
Nursing homes ()
All patients ()
OR
CI
%
%
%
Carbamazepine
134
21.0
55
22.4
189
21.4
0.88
0.61–1.26
Pregabalin
95
14.9
50
20.4
145
16.4
0.80
0.54–1.18
Lamotrigine
102
16.0
32
13.1
134
15.2
1.15
0.74–1.79
Gabapentin
104
16.3
29
11.8
133
15.1
1.72
1.09–2.70
Valproate
66
10.4
27
11.0
93
10.5
0.78
0.48–1.26
Clonazepam
60
9.4
27
11.0
87
9.9
0.79
0.49–1.29
Phenobarbital
48
7.5
15
6.1
63
7.1
1.26
0.68–2.31
Levetiracetam
49
7.7
12
4.9
61
6.9
1.46
0.76–2.81
Phenytoin
29
4.6
10
4.1
39
4.4
1.08
0.51–3.99
Oxcarbazepine
11
1.7
10
4.1
21
2.4
0.36
0.15–0.86
Topiramate
4
0.6
1
0.4
5
0.6
1.29
0.14–11.83
Zonisamide
3
0.5
0
0
3
0.3
—
—
Primidone
1
0.2
0
0
1
0.1
—
—
Total
706
268
974
Not marketed in Norwegian. Some patients used more than one antiepileptic drug. OR, odds ratio; CI, confidence interval (95%).
